<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: hiv patients</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>French patients keep HIV at bay despite stopping drugs (Update)</title>
   	 <description>A small French study of 14 HIV patients who have remained healthy for years after stopping drug treatment offers fresh evidence that early medical intervention may lead to a &quot;functional cure&quot; for AIDS, researchers said Thursday.</description>
     <link>http://medicalxpress.com/news/2013-03-french-patients-hiv-bay-drugs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 14 Mar 2013 17:09:00 EST</pubDate>
	 <guid isPermaLink="false">news282499733</guid>
	 
</item>
<item>
     <title>Computer models predict how patients will respond to HIV drugs</title>
   	 <description>Results of a study published online in the Journal of Antimicrobial Chemotherapy today (Thursday), demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. Crucially for patients in poorer countries, the models do not require the results of expensive drug resistance tests to make their predictions. The study also showed that the models were able to identify alternative drug combinations that were predicted to work in cases where the treatment used in the clinic had failed, suggesting that their use could avoid treatment failure.</description>
     <link>http://medicalxpress.com/news/2013-03-patients-hiv-drugs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 13 Mar 2013 20:10:01 EST</pubDate>
	 <guid isPermaLink="false">news282421952</guid>
	 
</item>
<item>
     <title>Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens</title>
   	 <description>A study led by University of Massachusetts Medical School professor and immunologist Katherine Luzuriaga, MD, and Johns Hopkins Children's Center virologist Deborah Persaud, MD, highlights the long-term benefits of early antiretroviral therapy (ART) initiated in infants.</description>
     <link>http://medicalxpress.com/news/2013-03-early-antiretroviral-treatment-viral-reservoirs.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 04 Mar 2013 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news281624209</guid>
	 
</item>
<item>
     <title>Researchers describe first 'functional HIV cure' in an infant</title>
   	 <description>A team of researchers from Johns Hopkins Children's Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called &quot;functional cure&quot; in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.</description>
     <link>http://medicalxpress.com/news/2013-03-functional-hiv-infant.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Sun, 03 Mar 2013 16:39:40 EST</pubDate>
	 <guid isPermaLink="false">news281551169</guid>
	 
</item>
<item>
     <title>Young males with HIV face greater risk of hearing loss</title>
   	 <description>(HealthDay)—HIV infection is significantly associated with an increased risk of developing sudden sensorineural hearing loss (SSHL), according to research published online Feb. 21 in JAMA Otolaryngology-Head &amp; Neck Surgery.</description>
     <link>http://medicalxpress.com/news/2013-03-young-males-hiv-greater-loss.html</link>
	 <category>Surgery</category>
	 <pubDate>Fri, 01 Mar 2013 13:33:00 EST</pubDate>
	 <guid isPermaLink="false">news281367166</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/youngmaleswi.jpg" width="90" height="90" />
</item>
<item>
     <title>Scale-up of HIV treatment in rural South Africa dramatically increases adult life expectancy</title>
   	 <description>The large antiretroviral treatment (ART) scale-up in a rural community in KwaZulu-Natal, South Africa, has led to a rapid and dramatic increase in population adult life expectancy—a gain of 11.3 years over eight calendar years (2004-2011)—and the benefit of providing ART far outweighs the cost, according to new research from Harvard School of Public Health (HSPH).</description>
     <link>http://medicalxpress.com/news/2013-02-scale-up-hiv-treatment-rural-south.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 21 Feb 2013 14:00:23 EST</pubDate>
	 <guid isPermaLink="false">news280676191</guid>
	 
</item>
<item>
     <title>Patient satisfaction leads to better HIV care</title>
   	 <description>In a study of patients at two HIV clinics in the Houston area, researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center found that those who were satisfied with the care they received had higher adherence to care and higher retention rates. Their report appears today in PLOS ONE.</description>
     <link>http://medicalxpress.com/news/2013-01-patient-satisfaction-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 30 Jan 2013 17:13:42 EST</pubDate>
	 <guid isPermaLink="false">news278788362</guid>
	 
</item>
<item>
     <title>Personalized plans to address barriers to HIV drug adherence boost chances of successful therapy</title>
   	 <description>HIV patients who participated in an intervention that helped them identify barriers to taking their drugs properly and develop customized coping strategies took a significantly greater amount of their prescribed doses than those receiving standard care, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania. The results, published this week in JAMA Internal Medicine, may point to a new strategy to improve adherence to medications for many other conditions.</description>
     <link>http://medicalxpress.com/news/2013-01-personalized-barriers-hiv-drug-adherence.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 29 Jan 2013 11:57:23 EST</pubDate>
	 <guid isPermaLink="false">news278683034</guid>
	 
</item>
<item>
     <title>Study reveals two-fold higher incidence of non-melanoma skin cancers for HIV patients</title>
   	 <description>HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal cell and squamous cell carcinomas occur more than twice as often among HIV-positive individuals compared to those who are HIV-negative.</description>
     <link>http://medicalxpress.com/news/2013-01-reveals-two-fold-higher-incidence-non-melanoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 29 Jan 2013 10:28:30 EST</pubDate>
	 <guid isPermaLink="false">news278677701</guid>
	 
</item>
<item>
     <title>Could probiotics help HIV patients?</title>
   	 <description>Antiretroviral (ARV) drugs are the first line therapy for patients with HIV; however, ARV-treated, HIV-infected individuals still have a higher mortality rate than uninfected individuals. During the course of infection, HIV patients develop inflammation that damages the walls of the intestines, known as the gut mucosa, allowing intestinal microbes to escape and enter the blood stream to cause a life-threatening systemic infection. The health of the gut mucosa is significantly influenced by the complement of bacteria in the gut and there is mounting evidence that probiotic supplements benefit patients intestinal disorders, such as irritable bowel syndrome, C. difficile infection, and inflammatory bowel disease.</description>
     <link>http://medicalxpress.com/news/2013-01-probiotics-hiv-patients.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 16 Jan 2013 12:00:08 EST</pubDate>
	 <guid isPermaLink="false">news277556199</guid>
	 
</item>
<item>
     <title>Feds warned against risk seen in Buffalo VA</title>
   	 <description>(AP)—Authorities are asking why a Buffalo veterans hospital may have reused insulin pens on many patients, causing an HIV scare, despite federal advice to the contrary.</description>
     <link>http://medicalxpress.com/news/2013-01-feds-buffalo-va.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 14 Jan 2013 16:38:30 EST</pubDate>
	 <guid isPermaLink="false">news277403902</guid>
	 
</item>
<item>
     <title>Better care from doctors who are culturally aware</title>
   	 <description>HIV patients from ethnic minorities receive better quality of care from doctors and other primary healthcare professionals who are the most competent at caring for patients from diverse backgrounds – those who are &quot;culturally competent.&quot; These patients also tend to manage both their treatment and condition better, according to a new study by Somnath Saha from Portland VA Medical Center, and the Oregon Health &amp; Science University in the US, and colleagues. Their findings appear in the Journal of General Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-01-doctors-culturally-aware.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 14 Jan 2013 11:14:35 EST</pubDate>
	 <guid isPermaLink="false">news277384469</guid>
	 
</item>
<item>
     <title>Scientists say vaccine temporarily brakes HIV</title>
   	 <description>A team of Spanish researchers say they have developed a therapeutic vaccine that can temporarily brake growth of the HIV virus in infected patients.</description>
     <link>http://medicalxpress.com/news/2013-01-scientists-vaccine-temporarily-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 03 Jan 2013 08:26:58 EST</pubDate>
	 <guid isPermaLink="false">news276423978</guid>
	 
</item>
<item>
     <title>In Ethiopia, HIV disclosure is low</title>
   	 <description>In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive status disclosure rates among men and women in Africa's second most populous country.</description>
     <link>http://medicalxpress.com/news/2013-01-ethiopia-hiv-disclosure.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 02 Jan 2013 14:32:41 EST</pubDate>
	 <guid isPermaLink="false">news276359553</guid>
	 
</item>
<item>
     <title>HIV patients in care lose more years of life to smoking than to HIV infection</title>
   	 <description>Among HIV patients receiving well-organized care with free access to antiretroviral therapy, those who smoke lose more years of life to smoking than to HIV, according to a Danish study published in Clinical Infectious Diseases and available online. The findings highlight the importance of smoking cessation efforts in the long-term, integrated care of patients infected with HIV.</description>
     <link>http://medicalxpress.com/news/2012-12-hiv-patients-years-life-infection.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 19 Dec 2012 00:00:02 EST</pubDate>
	 <guid isPermaLink="false">news275073204</guid>
	 
</item>
<item>
     <title>Atherosclerosis found in HIV children</title>
   	 <description>Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy lifestyles are needed to prevent early death from cardiovascular disease.</description>
     <link>http://medicalxpress.com/news/2012-12-atherosclerosis-hiv-children.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 05 Dec 2012 04:48:36 EST</pubDate>
	 <guid isPermaLink="false">news273905307</guid>
	 
</item>
<item>
     <title>No benefit from high-dose multivitamins seen for HIV patients receiving antiretroviral therapy</title>
   	 <description>A new study by Harvard School of Public Health (HSPH) researchers suggests that, for HIV patients receiving highly active antiretroviral therapy (HAART) to treat HIV, there is no benefit from high- vs. standard-dose micronutrient supplementation—and that, in fact, high-dose supplements may cause harm. The study is the first large randomized trial to look at how high-dose multivitamin supplementation affects clinical outcomes among people on HAART.</description>
     <link>http://medicalxpress.com/news/2012-10-benefit-high-dose-multivitamins-hiv-patients.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 16 Oct 2012 16:00:15 EST</pubDate>
	 <guid isPermaLink="false">news269614593</guid>
	 
</item>
<item>
     <title>HIV drug shows efficacy in treating mouse models of HER2+ breast cancer</title>
   	 <description>The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the National Cancer Institute.</description>
     <link>http://medicalxpress.com/news/2012-10-hiv-drug-efficacy-mouse-her2.html</link>
	 <category>Cancer</category>
	 <pubDate>Sat, 06 Oct 2012 07:14:51 EST</pubDate>
	 <guid isPermaLink="false">news268726474</guid>
	 
</item>
<item>
     <title>Sugar-free approach to treating Kaposi sarcoma</title>
   	 <description>A sugar-loving protein drives the growth of Kaposi sarcoma (KS) tumors, according to a study published on October 1st in The Journal of Experimental Medicine. Interfering with these sugary interactions inhibited growth of Kaposi sarcomas in mice, hinting at the potential for new treatment strategies in humans.</description>
     <link>http://medicalxpress.com/news/2012-10-sugar-free-approach-kaposi-sarcoma.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Oct 2012 12:00:04 EST</pubDate>
	 <guid isPermaLink="false">news268308218</guid>
	 
</item>
<item>
     <title>Effective HIV care benefited all HIV patients, regardless of demographics and behavioral risk</title>
   	 <description>Improved treatment options, a multi-pronged treatment model, and federal funding from the Ryan White Program have helped an inner city Baltimore clinic improve outcomes for HIV patients across all groups, including those most often hardest hit by the disease. Published in Clinical Infectious Diseases, the results from the 15-year analysis of patients at a clinic serving a primarily poor, African-American patient population with high rates of injection drug use demonstrate what state-of-the-art HIV care can achieve, given appropriate support.</description>
     <link>http://medicalxpress.com/news/2012-09-effective-hiv-benefited-patients-demographics.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 28 Sep 2012 05:30:01 EST</pubDate>
	 <guid isPermaLink="false">news268026105</guid>
	 
</item>
<item>
     <title>BIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test</title>
   	 <description>A new postage stamp-sized, paper-based device could provide a simple and reliable way to monitor for liver damage at a cost of only pennies per test, say researchers at Beth Israel Deaconess Medical Center (BIDMC) and Diagnostics For All (DFA), a Cambridge, MA nonprofit dedicated to improving the health of people living in the developing world.</description>
     <link>http://medicalxpress.com/news/2012-09-bidmc-diagnostics-low-cost-paper-based-liver.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 19 Sep 2012 14:01:02 EST</pubDate>
	 <guid isPermaLink="false">news267281992</guid>
	 
</item>
<item>
     <title>New HIV/AIDS registry to help answer key questions</title>
   	 <description>A new community-based HIV/AIDS registry, one of the first in the nation to include patients from rural areas, will provide a unique opportunity to find answers to myriad medical questions, from the impact of drugs such as marijuana on the virus to why some patients naturally ward off the disease.</description>
     <link>http://medicalxpress.com/news/2012-08-hivaids-registry-key.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 29 Aug 2012 17:45:04 EST</pubDate>
	 <guid isPermaLink="false">news265481098</guid>
	 
</item>
<item>
     <title>Nurses as effective as doctors in treatment of HIV patients</title>
   	 <description>Nurse-centred care of HIV patients can be just as safe and effective as care delivered by doctors and has a number of specific health benefits, according to a new study led by the University of East Anglia (UEA) and the University of Cape Town (UCT).</description>
     <link>http://medicalxpress.com/news/2012-08-nurses-effective-doctors-treatment-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Tue, 14 Aug 2012 19:00:03 EST</pubDate>
	 <guid isPermaLink="false">news264165809</guid>
	 
</item>
<item>
     <title>Only 1 in 4 americans with HIV has virus under control: CDC</title>
   	 <description>(HealthDay) -- Among the 1.1 million Americans living with HIV, just one in four has the virus under control, U.S. health researchers say.</description>
     <link>http://medicalxpress.com/news/2012-07-americans-hiv-virus-cdc.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 27 Jul 2012 15:38:34 EST</pubDate>
	 <guid isPermaLink="false">news262622295</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/only1in4amer.jpg" width="90" height="85" />
</item>
<item>
     <title>Small breakthroughs offer big hope of AIDS 'cure'</title>
   	 <description> Small but significant breakthrough studies on people who have been able to overcome or control HIV were presented Thursday at a major world conference on ways to stem the three-decade-old disease.</description>
     <link>http://medicalxpress.com/news/2012-07-paths-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 26 Jul 2012 17:36:09 EST</pubDate>
	 <guid isPermaLink="false">news262542964</guid>
	 
</item>
<item>
     <title>Benefits of HIV drugs rise -- but less than previously believed, study shows</title>
   	 <description>The percentage of HIV patients taking antiretroviral drugs who experienced the full benefit of the drugs jumped from 45 percent of 72 percent during the past decade, a figure that is lower than previous estimates. The findings, considered important for HIV prevention efforts, since patients whose virus is in tight control are less likely to transmit the infection to others, are published this week in JAMA by a team of researchers led by the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins University School of Medicine. The issue's publication coincides with AIDS 2012, the annual international AIDS conference, being held in the United States for the first in over 20 years this week in Washington, D.C.</description>
     <link>http://medicalxpress.com/news/2012-07-benefits-hiv-drugs-previously.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Sun, 22 Jul 2012 15:12:22 EST</pubDate>
	 <guid isPermaLink="false">news262188661</guid>
	 
</item>
<item>
     <title>Study implements community-based approach to treat HIV-infection in rural Uganda</title>
   	 <description>New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers would typically prevent access to care.</description>
     <link>http://medicalxpress.com/news/2012-07-community-based-approach-hiv-infection-rural-uganda.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 19 Jul 2012 11:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261913813</guid>
	 
</item>
<item>
     <title>HIV drug reduces graft-vs.-host disease in bone marrow transplant patients</title>
   	 <description>An HIV drug that redirects immune cell traffic significantly reduces the incidence of a dangerous complication that often follows bone marrow transplants for blood cancer patients, according to research from the Perelman School of Medicine at the University of Pennsylvania that will be published today in the New England Journal of Medicine. The findings represent a new tactic for the prevention of graft-versus-host disease (GvHD), which afflicts up to 70 percent of transplant patients and is a leading cause of deaths associated with the treatment.</description>
     <link>http://medicalxpress.com/news/2012-07-hiv-drug-graft-vs-host-disease-bone.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 11 Jul 2012 17:00:04 EST</pubDate>
	 <guid isPermaLink="false">news261241119</guid>
	 
</item>
<item>
     <title>HIV may have returned in 'cured' patient: scientists</title>
   	 <description> An American man whose HIV seemed to disappear after a blood marrow transplant for leukemia may be showing new hints of the disease, sparking debate over whether a cure was really achieved.</description>
     <link>http://medicalxpress.com/news/2012-06-hiv-patient-scientists.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 13 Jun 2012 09:16:28 EST</pubDate>
	 <guid isPermaLink="false">news258797774</guid>
	 
</item>
<item>
     <title>Researchers find that pre-existing mutations can lead to drug resistance in HIV virus</title>
   	 <description>In a critical step that may lead to more effective HIV treatments, Harvard scientists have found that, in a small number of HIV patients, pre-existing mutations in the virus can cause it to develop resistance to the drugs used to slow the progression of the disease.</description>
     <link>http://medicalxpress.com/news/2012-06-pre-existing-mutations-drug-resistance-hiv.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Thu, 07 Jun 2012 17:00:24 EST</pubDate>
	 <guid isPermaLink="false">news258305965</guid>
	 
</item>


</channel>
</rss>
